ENVBEnveric Biosciences, Inc.同业对比
Enveric Biosciences, Inc. 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENVB本股 | $7M#8 | — | 0.8x#4 | 0.2x#1 | -7.2%#6 | 26.0%#11 | -22.0%#1 | 149.7%#1 | -100.4%#1 | 3#3 | -86.4%#10 | — |
| XCUR | $9M#1 | — | 9.0x#12 | — | -100.0%#9 | 49.0%#5 | — | -506.2%#12 | — | — | -64.6%#4 | — |
| TRAW | $8M#2 | — | 0.7x#3 | 2.9x#6 | 1134.5%#1 | 105.5%#1 | -640.7%#6 | 79.2%#2 | — | — | -75.7%#8 | — |
| SNGX | $8M#3 | — | 1.2x#8 | 65.8x#8 | -85.8%#8 | -33.7%#12 | -9923.2%#8 | -167.0%#7 | — | 5#1 | -87.0%#11 | — |
| IMNN | $8M#4 | — | — | — | — | — | — | — | — | — | -74.4%#7 | — |
| ACXP | $7M#5 | — | 0.9x#6 | — | — | 43.5%#8 | — | -97.7%#6 | — | — | -66.6%#5 | — |
| BOLT | $7M#6 | — | 0.6x#1 | 0.9x#3 | 0.1%#5 | 47.1%#6 | -469.3%#5 | -264.1%#10 | — | — | -28.8%#1 | — |
| SYBX | $7M#7 | — | 0.6x#2 | — | -100.0%#9 | 95.7%#2 | — | -8.4%#4 | — | — | -63.8%#3 | — |
| ERNA | $6M#9 | 0.1x#1 | 2.0x#10 | 11.0x#7 | 755.9%#2 | 68.4%#4 | -1601.2%#7 | -440.1%#11 | -1016.2%#4 | — | -87.4%#12 | — |
| PULM | $5M#11 | — | 2.0x#11 | 0.7x#2 | 7.0%#4 | 46.0%#7 | -66.2%#2 | -201.9%#8 | -235.7%#2 | — | -71.6%#6 | — |
| XBIO | $5M#12 | — | 0.9x#5 | 1.7x#5 | 19.0%#3 | 32.3%#10 | -95.2%#3 | -44.1%#5 | -1516.8%#5 | 4#2 | -35.3%#2 | — |
| LABT | $5M#13 | — | 1.2x#7 | — | — | — | — | 0.0%#3 | — | — | — | — |
| PRPH | $6M#10 | — | — | 1.3x#4 | -35.8%#7 | 72.4%#3 | -415.4%#4 | — | -804.6%#3 | — | -91.5%#13 | — |
| DRMA | $5M#14 | — | 1.3x#9 | — | — | 38.5%#9 | — | -216.7%#9 | — | — | -79.5%#9 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-16。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议